No Data
No Data
Lepu Medical Technology (300003.SZ) plans to distribute 1.42 yuan per 10 shares, ex-dividend on September 20th.
Lepu Medical Technology (300003.SZ) announced that the company plans to distribute half-yearly equity to all shareholders in 2024: 1...
Lepu Medical Technology (300003.SZ): Terminates the implementation of the 2022 restricted stock incentive plan.
Lepu Medical Technology (300003.SZ) announced on September 9th that the performance assessment target at the company level for the first vesting period of the 2022 restricted stock incentive plan has been successfully achieved. However, due to the changes in internal and external environments faced by the company's operation, the performance assessment target for the second vesting period could not be met. Furthermore, considering the significant fluctuation of the company's current stock price compared to the grant price, it will be difficult to achieve the expected incentive purpose and effect by continuing the implementation of this incentive plan. Taking into account market environment factors, the actual operation situation of the company, long-term strategic planning, and the willingness of incentive recipients, after careful consideration, the board of directors has decided to terminate the implementation of the plan.
Did the aftermath of Lepu Medical Technology's (300003.SZ) "merger and acquisition for growth" strategy show up, with declining performance and high goodwill?
The development risks of "merger maniac" lepu medical technology seem to be emerging.
Lepu Medical Technology plans to reduce its shareholding by no more than 2% in Shengnuo Biotechnology (688117.SH).
On September 3, J.LUNGHUI: | Shenno Biology (688117.SH) Announced that the company recently received a notification letter from shareholder Lepu Medical Technology Regarding the shareholding plan, Lepu Medical Technology intends to reduce its total holdings in the company by no more than 2,240,000 shares, i.e. not more than 2% of the total share capital, due to the shareholder's own fund needs. The portion to be reduced through centralized bidding will be carried out within 3 months after 15 trading days from the date of this announcement, and the total number of shares to be reduced in any 90 consecutive natural days shall not exceed 1% of the total number of company shares.
lepu medical technology (300003.SZ): cumulative repurchase of 1.01% of the company's shares
Lepu Medical Technology (300003.SZ) announced on August 30th that, as of the disclosure date of this announcement, the company has repurchased a total of 18,942,200 shares of the company through a repurchase special securities account through centralized bidding trading, accounting for 1.01% of the total share capital of the company. The highest fill price was 16.65 yuan/share, the lowest fill price was 9.45 yuan/share, and the total transaction amount was 252,645,221.73 yuan (excluding transaction costs).
Lepu Medical Technology: Summary of Half-Year Report in 2024.
No Data
No Data